Quantification of Drug Release Degree In Vivo Using Antibody-Guided, Dual-NIR-Dye Ratiometric System.
Ebaston ThankarajanSuchita JadhavGalia LuboshitsGary GellermanLeonid D PatsenkerPublished in: Analytical chemistry (2021)
Fluorescent dyes linked to drug delivery systems provide important real-time information on the efficacy of drug delivery. However, the quantitative monitoring of drug distribution is challenging because of interferences from the biological sample and instrumental setup. To improve quantification of anticancer drug delivery followed by drug release in tumor, we equipped an antibody-drug conjugate (ADC) with a turn-on near-infrared (NIR) dye, sensitive to drug release, and a reference NIR dye. In this study, chlorambucil (CLB) was chosen as a model anticancer drug and Trastuzumab monoclonal antibody specific to Her2 receptors overexpressed in many tumors was taken as the carrier. The advantage of the obtained dual-dye ratiometric system for drug release monitoring was demonstrated in mice model.
Keyphrases
- drug release
- drug delivery
- living cells
- fluorescent probe
- cancer therapy
- monoclonal antibody
- quantum dots
- highly efficient
- sensitive detection
- aqueous solution
- hydrogen peroxide
- high resolution
- healthcare
- epidermal growth factor receptor
- skeletal muscle
- metabolic syndrome
- nitric oxide
- visible light
- adverse drug
- adipose tissue
- drug induced
- emergency department
- computed tomography
- photodynamic therapy
- metastatic breast cancer
- mass spectrometry
- electronic health record